SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
01 1SCI PHARMTECH, INC.
01 1PROBUCOL
01 1Taiwan
SCI Pharmtech offers high-quality, cost-effective APIs, advanced intermediates, & custom products with global expertise and precision.
NDC Package Code : 68108-0304
Start Marketing Date : 2004-06-14
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
73
PharmaCompass offers a list of Probucol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Probucol manufacturer or Probucol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Probucol manufacturer or Probucol supplier.
A Panavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Panavir, including repackagers and relabelers. The FDA regulates Panavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Panavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Panavir manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Panavir supplier is an individual or a company that provides Panavir active pharmaceutical ingredient (API) or Panavir finished formulations upon request. The Panavir suppliers may include Panavir API manufacturers, exporters, distributors and traders.
click here to find a list of Panavir suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Panavir as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Panavir API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Panavir as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Panavir and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Panavir NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Panavir suppliers with NDC on PharmaCompass.
